{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T20:24:01Z","timestamp":1790281441739,"version":"4.1.0"},"reference-count":38,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2010,5]]},"DOI":"10.1097\/nrl.0b013e31819f952b","type":"journal-article","created":{"date-parts":[[2010,5,5]],"date-time":"2010-05-05T08:44:42Z","timestamp":1273049082000},"page":"192-195","source":"Crossref","is-referenced-by-count":25,"title":["Compulsive Behaviors in Patients With Parkinson's Disease"],"prefix":"10.1097","volume":"16","author":[{"given":"G\u00fclay","family":"Kenangil","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sibel","family":"\u00d6zekmek\u00e7i","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melis","family":"Sohtaoglu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ethem","family":"Ergin\u00f6z","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-7-20210211","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1097\/01.wco.0000137528.23126.41","article-title":"Dopamin dysregulation syndrome in Parkinson's disease.","volume":"17","author":"Evans","year":"2004","journal-title":"Curr Opin Neurol"},{"key":"R2-7-20210211","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1002\/mds.21296","article-title":"Punding prevalence in Parkinson's disease.","volume":"22","author":"Miyasaki","year":"2007","journal-title":"Mov Disord"},{"key":"R3-7-20210211","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1136\/jnnp.68.4.423","article-title":"Hedonistic homeostatic dysregulation in patients with Parkinson's disease on dopamine replacement therapies.","volume":"68","author":"Giovannoni","year":"2000","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"R4-7-20210211","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1097\/NRL.0b013e31816606a7","article-title":"Impulse control disorders and pathological gambling in patients with Parkinson disease.","volume":"14","author":"Stamey","year":"2008","journal-title":"Neurologist"},{"key":"R5-7-20210211","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1002\/mds.20288","article-title":"Prevalence and clinical features of Hedonistic homeostatic dysregulation in Parkinson's disease.","volume":"20","author":"Pezzella","year":"2005","journal-title":"Mov Disord"},{"key":"R6-7-20210211","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1212\/01.wnl.0000238401.76928.45","article-title":"Clinical features associated with impulse control disorders in Parkinson disease.","volume":"67","author":"Pontone","year":"2006","journal-title":"Neurology"},{"key":"R7-7-20210211","doi-asserted-by":"crossref","first-page":"1750","DOI":"10.1212\/01.wnl.0000218206.20920.4d","article-title":"Prospective prevalance of pathological gambling and medication association in Parkinson's disease.","volume":"66","author":"Voon","year":"2006","journal-title":"Neurology"},{"key":"R8-7-20210211","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.1002\/mds.21611","article-title":"Pathological gambling in Parkinson's disease: risk factors and differences from dopamine dysregulation. An analysis of published case series.","volume":"22","author":"Gallagher","year":"2007","journal-title":"Mov Disord"},{"key":"R9-7-20210211","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1212\/01.WNL.0000076478.45005.EC","article-title":"Pathological gambling associated with dopamine agonist therapy in Parkinson's disease.","volume":"61","author":"Driver-Dunckley","year":"2003","journal-title":"Neurology"},{"key":"R10-7-20210211","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1001\/archneur.62.9.noc50009","article-title":"Pathological gambling caused by drugs used to treat Parkinson disease.","volume":"62","author":"Dodd","year":"2005","journal-title":"Arch Neurol"},{"key":"R11-7-20210211","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1212\/01.wnl.0000238503.20816.13","article-title":"Prevalance of repetitive and reward-seeking behaviors in Parkinson's disease.","volume":"67","author":"Voon","year":"2006","journal-title":"Neurology"},{"key":"R12-7-20210211","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1001\/archneur.63.7.969","article-title":"Dopamine agonist use is associated with impulse control disorders in Parkinson's disease.","volume":"63","author":"Weintraub","year":"2006","journal-title":"Arch Neurol"},{"key":"R13-7-20210211","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.parkreldis.2005.06.005","article-title":"Pathological hypersexuality predominantly linked to adjuvant dopamine agonist therapy in Parkinson disease and multiple system atrophy.","volume":"11","author":"Klos","year":"2005","journal-title":"Parkinsonism Relat Disord"},{"key":"R14-7-20210211","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1002\/mds.20757","article-title":"Compulsive eating and weight gain related to dopamine agonist use.","volume":"21","author":"Nirenberg","year":"2006","journal-title":"Mov Disord"},{"key":"R15-7-20210211","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1002\/mds.20045","article-title":"Punding in Parkinson's Disease: its relation to the dopamine dysregulation syndrome.","volume":"19","author":"Evans","year":"2004","journal-title":"Mov Disord"},{"key":"R16-7-20210211","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1002\/1531-8257(199909)14:5<836::AID-MDS1018>3.0.CO;2-0","article-title":"Punding on l-Dopa.","volume":"14","author":"Fernandez","year":"1999","journal-title":"Mov Disord"},{"key":"R17-7-20210211","doi-asserted-by":"crossref","first-page":"2339","DOI":"10.1002\/mds.21702","article-title":"Predictors of punding in Parkinson's disease: results from a questionnaire survey.","volume":"22","author":"Lawrence","year":"2007","journal-title":"Mov Disord"},{"key":"R18-7-20210211","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1212\/01.wnl.0000184487.72289.f0","article-title":"Factors influencing susceptibility to compulsive dopaminergic drug use in Parkinson's disease.","volume":"65","author":"Evans","year":"2005","journal-title":"Neurology"},{"key":"R19-7-20210211","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1177\/0269881106073109","article-title":"New onset heightened interest or drive for gambling, shopping, eating or sexual activity in patients with Parkinson's disease: the role of dopamine agonist treatment and age at motor symptoms onset.","volume":"21","author":"Giladi","year":"2007","journal-title":"J Psychopharmacol"},{"key":"R20-7-20210211","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/j.parkreldis.2007.04.004","article-title":"Unusual compulsive behaviors primarily to dopamine agonist therapy in Parkinson's disease and multiple system atrophy.","volume":"13","author":"McKeon","year":"2007","journal-title":"Parkinsonism Relat Disord"},{"key":"R21-7-20210211","doi-asserted-by":"crossref","first-page":"2206","DOI":"10.1002\/mds.21110","article-title":"Problematic gambling on dopamine agonists: not such a rarity.","volume":"21","author":"Grosset","year":"2006","journal-title":"Mov Disord"},{"key":"R22-7-20210211","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1002\/mds.21770","article-title":"Long-term follow-up of impulse control disorders in Parkinson's disease.","volume":"23","author":"Mamikonyan","year":"2008","journal-title":"Mov Disord"},{"key":"R23-7-20210211","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1212\/WNL.42.6.1142","article-title":"What features improve the accuracy of clinical diagnosis in Parkinson's disease: a clinicopathologic study.","volume":"42","author":"Hughes","year":"1992","journal-title":"Neurology"},{"key":"R24-7-20210211","article-title":"Diagnostic and Statistical Manual of Mental Disorders. 4th ed.","year":"1994"},{"issue":"suppl","key":"R25-7-20210211","first-page":"90","article-title":"Pathological gambling in Parkinson's disease.","volume":"5","author":"Molina","year":"1999","journal-title":"Parkinsonism Relat Disord"},{"key":"R26-7-20210211","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1097\/00002826-198910000-00002","article-title":"Hypersexuality with antiparkinsonian therapy.","volume":"12","author":"Uitti","year":"1989","journal-title":"Clin Neuropharmacol"},{"key":"R27-7-20210211","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/0022-3956(75)90026-6","article-title":"Mini mental state. A practical method for grading the cognitive state of patients for clinician.","volume":"12","author":"Folstein","year":"1975","journal-title":"J Psychiatr Res"},{"key":"R28-7-20210211","first-page":"53","article-title":"Recent Developments in Parkinson's Disease.","author":"Fahn","year":"1987"},{"key":"R29-7-20210211","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1093\/brain\/123.4.733","article-title":"Hallucinations in Parkinson's disease. Prevalence, phenomenology and risk factors.","volume":"123","author":"Fenelon","year":"2000","journal-title":"Brain"},{"key":"R30-7-20210211","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1212\/WNL.52.6.1227","article-title":"Switching dopamine agonists in advanced Parkinson's disease. Is rapid titration preferable to slow?","volume":"52","author":"Goetz","year":"1999","journal-title":"Neurology"},{"key":"R31-7-20210211","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1002\/mds.20210","article-title":"Switching from ergot to nonergot dopamine agonists in Parkinson's disease: a clinical series and five-drug dose conversion table.","volume":"19","author":"Grosset","year":"2004","journal-title":"Mov Disord"},{"key":"R32-7-20210211","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1001\/archneur.64.2.212","article-title":"Factors associated with dopaminergic drug- related pathological gambling in Parkinson disease.","volume":"64","author":"Voon","year":"2007","journal-title":"Arch Neurol"},{"key":"R33-7-20210211","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.parkreldis.2007.05.006","article-title":"Predictors of impulsivity and reward seeking behavior with dopamine agonists.","volume":"14","author":"Ondo","year":"2008","journal-title":"Parkinsonism Relat Disord"},{"key":"R34-7-20210211","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1002\/mds.21872","article-title":"The relationship between impulsivity and impulse control disorders in Parkinson's disease.","volume":"23","author":"Isaias","year":"2008","journal-title":"Mov Disord"},{"key":"R35-7-20210211","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1016\/j.parkreldis.2006.02.004","article-title":"Dopamine agonist therapy for Parkinson disease and pathological gambling.","volume":"12","author":"Imamura","year":"2006","journal-title":"Parkinsonism Relat Disord"},{"key":"R36-7-20210211","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.parkreldis.2006.08.003","article-title":"Dopamine agonists and pathological gambling.","volume":"13","author":"Grosset","year":"2007","journal-title":"Parkinsonism Relat Disord"},{"key":"R37-7-20210211","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1002\/1531-8257(200009)15:5<869::AID-MDS1016>3.0.CO;2-I","article-title":"Pathologic gambling in Parkinson's disease: a behavioral manifestation of pharmacologic treatment?","volume":"15","author":"Molina","year":"2000","journal-title":"Mov Disord"},{"key":"R38-7-20210211","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.drugalcdep.2004.06.005","article-title":"Recognition of a dopamine replacement therapy dependence syndrome in Parkinson's disease: a pilot study.","volume":"76","author":"Bearn","year":"2004","journal-title":"Drug Alcohol Depend"}],"container-title":["The Neurologist"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/journals.lww.com\/00127893-201005000-00007","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,10]],"date-time":"2021-04-10T06:24:19Z","timestamp":1618035859000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00127893-201005000-00007"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,5]]},"references-count":38,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2010]]}},"URL":"https:\/\/doi.org\/10.1097\/nrl.0b013e31819f952b","relation":{},"ISSN":["1074-7931"],"issn-type":[{"value":"1074-7931","type":"print"}],"subject":[],"published":{"date-parts":[[2010,5]]}}}